Related Experiment Video
Updated: Apr 28, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Non-invasive CT-based Deep Learning for Human Papillomavirus Status Prediction in Oropharyngeal Cancer
Junhua Chen1, Mayuan Meng2, Shuai Kuang3
1School of Medicine, Shanghai University, Shanghai 200444, China (J.C., B.Y.).
A novel AI method accurately predicts human papillomavirus (HPV) status in oropharyngeal cancer (OPC) using CT scans. This non-invasive approach shows performance comparable to clinical standards, aiding treatment decisions.
Area of Science:
- Radiogenomics
- Artificial Intelligence in Oncology
- Medical Imaging Analysis
Background:
- Human papillomavirus (HPV) status is crucial for oropharyngeal cancer (OPC) treatment planning.
- Current methods for HPV classification require additional examinations.
- There is a need for non-invasive, rapid alternatives for HPV status determination.
Purpose of the Study:
- To develop a non-invasive and rapid AI-based method for HPV classification in OPC.
- To achieve performance comparable to established clinical standards.
- To integrate HPV classification into routine diagnostic and treatment workflows.
Main Methods:
- Utilized a siamese neural network with 3D DenseNet backbones.
- Incorporated tumor mask volumes and frequency-domain CT image representations.
- Trained and validated the model on 1612 cases across three independent datasets.
Main Results:
- Achieved an average AUC of 0.875 and AUPRC of 0.922.
- Demonstrated superior performance compared to reference methods across four key metrics.
- External validation showed robust generalizability with AUCs ranging from 0.726 to 0.839.
Conclusions:
- The proposed CT-based radiogenomics method achieves state-of-the-art performance for HPV prediction in OPC.
- The approach demonstrates performance comparable to existing clinical methods.
- The AI model shows "good-enough" performance for supporting patient decision-making in clinical trials, aligning with FDA guidelines.
More Related Videos
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017